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Abstract: In this work, two bioactive glass powders (SBA2 and SBA3) were doped with Cu
by means of the ion-exchange technique in aqueous solution. SBA2 glass was subjected to
the ion-exchange process by using different Cu salts (copper(II) nitrate, chloride, acetate, and
sulphate) and concentrations. Structural (X-ray diffraction-XRD), morphological (Scanning Electron
Microscopy-SEM), and compositional (Energy Dispersion Spectrometry-EDS) analyses evidenced
the formation of crystalline phases for glasses ion-exchanged in copper(II) nitrate and chloride
solutions; while the ion-exchange in copper(II) acetate solutions lead to the incorporation of higher
Cu amount than the ion-exchange in copper(II) sulphate solutions. For this reason, the antibacterial
test (inhibition halo towards S. aureus) was performed on SBA2 powders ion-exchanged in copper(II)
acetate solutions and evidenced a limited antibacterial effect. A second glass composition (SBA3)
was developed to allow a greater incorporation of Cu in the glass surface; SBA3 powders were
ion-exchanged in copper(II) acetate solutions (0.01 M and 0.05 M). Cu-doped SBA3 powders showed
an amorphous structure; morphological analysis evidenced a rougher surface for Cu-doped powders
in comparison to the undoped glass. EDS and X-ray photoelectron spectroscopy (XPS) confirmed
the Cu introduction as Cu(II) ions. Bioactivity test in simulated body fluid (SBF) showed that Cu
introduction did not alter the bioactive behaviour of the glass. Finally, inhibition halo test towards
S. aureus evidenced a good antimicrobial effect for glass powders ion-exchanged in copper(II) acetate
solutions 0.05 M.
Keywords: bioactive glasses; ion-exchange; copper; antibacterial
1. Introduction
Bioactive glasses have been widely investigated in the orthopaedic and dental fields for their
ability to chemically bond to living bone through a well-known process, which involves a rapid
ion-exchange between glass and surrounding biological fluids, the formation of silica-rich layer, the
incorporation of calcium and phosphates, and the crystallization of biologically active hydroxyapatite
(HAp) on their surface [1–4]. The peculiar surface reactivity of bioactive glasses and their corresponding
glass-ceramics has been object of investigation for many years, since several authors focalized their
attention on the multi-step mechanism for the formation of the HAp layer, which was considered
the critical stage for bone healing [1–7]. Today, bioactivity (i.e., the ability to form strong bonds to
bone) is considered a useful stage for bone regeneration, but not the critical one. Recent studies
report that the release of ionic dissolution products (such as Si4+, Mg2+, Ca2+) from the bioactive glass
surface has stimulating effects on bone formation, playing a key role in the early stages of the bone
regeneration processes [8–10]. For this reason, bioactive glass surfaces can stimulate both intracellular
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and extracellular responses and, in turn can be actively mineralized in vivo. The in vivo colonization
of osteogenic stem cells and the stimulation of angiogenesis seem to be promoted by contact with
bioactive glasses [8]. For these reasons, a new promising research field has been recently proposed—i.e.,
the “genetic design” of new bioactive glass formulations [11] by doping silicate and phosphate glasses
with several active ions, including trace elements [12,13].
Recently, some authors explored the aptitude of bioactive glasses to stimulate and regenerate
soft tissues [10,14,15], and they proved that several processes that control soft tissue regeneration
in the early steps can be regulated by the release of ions from bioactive glasses. In this prospective,
several bioactive glass compositions containing specific metallic ions (Sr, Cu, Ag, Zn, etc., reported as
“bioinorganics”) with therapeutic effects were investigated [9,16,17].
Among the explored therapeutic agents, Cu was initially studied for its ability to induce
differentiation of mesenchymal cells towards the osteogenic lineage [18]. More recently, a significant
amount of cellular Cu has been found in human endothelial cells during angiogenesis [19], and its
ability to stimulate the proliferation of endothelial cells has been investigated [20]. Some authors
evidenced the ability of copper ions to promote angiogenesis [21,22] in particular by synergistic
stimulating effects when associated with angiogenic growth factor FGF-2 [23]. Moreover, copper is
also well known for its antimicrobial properties [24,25].
Silica-based Cu-containing bioactive glasses were obtained mainly by sol–gel process [26–29],
evidencing the ability to incorporate copper up to 10% mol; the traditional melt and quenching
technique was also adopted both for silica-based bioactive glasses [30] and phosphate glasses [31,32],
demonstrating that the glass degradation and the consequent release of copper ions significantly
reduced the bacterial adhesion and proliferation.
Moreover, Wu et al., synthesized Cu-containing mesoporous bioactive scaffolds, which promoted
the osteogenic differentiation of human bone marrow stromal cells, enhanced hypoxia-like tissue
reaction, and showed antibacterial properties towards E. coli, thus combining angiogenesis,
osteogenesis and antibacterial properties [33].
The ion-exchange process was also used to dope the surface of glasses (mainly soda-lime glass
and Schott BK7 glass) with copper ions [34–38]. To the authors’ knowledge, this process was always
performed in molten salts using different Cu salts, such as CuCl2, CuCl, CuCl:KCl and CuSO4:Na2SO4,
or vapour of CuCl:KCl, and it was not applied to bioactive glass compositions.
In the present paper, the possibility to use the ion-exchange technique in aqueous solution to
introduce copper in the outer layer of two different silica-based bioactive glasses was investigated
for the first time by examining the effect of the process and the Cu introduction on the structure,
morphology, composition, bioactive, and antibacterial properties of the glasses.
2. Materials and Methods
2.1. SBA2 Synthesis and Characterization
A bioactive glass with the composition of (mol %) 48% SiO2, 18% Na2O, 30% CaO, 3% P2O5, 0.43%
B2O3, 0.57% Al2O3 (SBA2) was produced by means of melt and quenching technique. Briefly, the
reactants were mechanically mixed, melted in a platinum crucible at 1450 ˝C for 1 h. Subsequently, the
melt was cooled in water at room temperature obtaining a frit, which was mechanically milled in a
zirconia jar and sieved to a final grain size <20 µm.
The obtained glass powders were subjected to an ion-exchange process; this technique is a mass
transfer driven by concentration gradients, in which ions present in the surface of the glass (usually
monovalent ions) diffuse out of the glass surface and are replaced by different ions coming from a
molten salt bath or an aqueous solution. In this work, the process was performed in aqueous solution
containing different Cu salts in different concentrations, as shown in Table 1, in order to introduce
copper ions in the glass network.
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Table 1. Investigated conditions of ion-exchange.
Copper Salts 0.01 M 0.05 M 0.1 M
Copper(II) nitrate Cu(NO3)2¨ 3H2O x x x
Copper(II) chloride CuCl2¨ 2H2O x x x
Copper(II) acetate Cu(CH3COO)2¨H2O x x
Copper(II) sulphate CuSO4 x x
In all experiments, 1 g of glass powder was immersed in 20 mL of solution and maintained at
37 ˝C for 1 h at 150 rpm to allow the exchange of copper ions with modifier ions of the glass (Na+ and
Ca2+). Then, the solution was removed, the powders were washed two times with bi-distilled water,
filtered using disk filter paper, and dried at 60 ˝C for 12 h.
The obtained powders were characterized in terms of structure by means of X-ray diffraction
(XRD—X’Pert Philips diffractometer, PANalytical, Eindhoven, The Netherlands) to evaluate the
possible formation of crystalline phases, using the Bragg Brentano camera geometry and the Cu-Ka
incident radiation. The obtained pattern was analysed with X’Pert High Score software (2.2b) and the
PCPDFWIN database (http://pcpdfwin.updatestar.com/).
The morphology and composition of ion-exchanged glass powders were analysed by means
of Scanning Electron Microscopy (SEM, QUANTA INSPECT 200, FEI, Eindhoven, The Netherlands)
equipped with Energy Dispersion Spectrometry (EDSPV 9900, EDAX, Mahwah, NJ, USA) to estimate
the influence of the ion-exchange process on the glass powders and to verify the presence of Cu.
On the basis of structural and morphological-compositional characterizations, SBA2 powders
ion-exchanged in a solution 0.01 M of copper acetate was selected to verify the antibacterial effect
of Cu-doped glass. In order to perform the antibacterial ability test, 200 mg of glass powders were
weighed and pressed at 4 tons for 10 s in an automatic press (Graseby T-40, Specac, Kent, UK) to
obtain pellets. The inhibition halo test (Kirby Bauer test) was performed in accordance with NCCLS
normative [39] using a standard Staphylococcus aureus strain (ATCC 29213).
S. aureus was selected since it is one of the strains mainly involved in the development of
infection [40] and since the Gram positive strains are generally more resistant to the effects of
antibacterial agents [41].
Briefly, a 0.5 McFarland solution, containing approximately 1 ˆ 108 colony forming units
(CFU)/mL, was prepared by dissolving some S. aureus colonies, grown on blood agar plate, in
physiological solution; the turbidity of the solution was evaluated by optical instrument—Phoenix
Spec BD McFarland (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). This bacterial
suspension was uniformly spread on Mueller Hinton agar plate (Becton, Dickinson and Company,
Franklin Lakes, NJ, USA), glass pellets were placed in contact with the agar and incubated overnight
at 37 ˝C. At the end of incubation, the inhibition zone was observed and measured.
2.2. SBA3 Synthesis and Characterization
On the basis of the results obtained from Cu-doped SBA2 characterizations—in particular the
amount of Cu introduced without affecting the glass structure and the antibacterial test (as reported in
the following sections)—a second glass composition (SBA3) was developed in order to allow a greater
incorporation of Cu in the glass surface. The SBA3 presents the following molar composition: 48%
SiO2, 26% Na2O, 22% CaO, 3% P2O5, 0.43% B2O3, 0.57% Al2O3. In particular, the amount of Na2O was
increased in order to increase the quantity of mobile monovalent ions as well as to produce a more
opened amorphous network and enhance the reactivity, thus promoting the exchange of all modifier
ions with copper ions.
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SBA3 powders were obtained by means of melting and quenching process: SBA3 precursors
were melted in a platinum crucible at 1450 ˝C for 1 h and cooled in water to obtain a frit, which was
mechanically milled in a zirconia jar and sieved to a final grain size <20 µm.
Considering the ion-exchange conditions that allowed the introduction of Cu in the SBA2 glass
without the formation of crystalline phases (as reported in the following sections), SBA3 powders (1 g)
were ion-exchanged in aqueous solution of copper acetate 0.01 M and 0.05 M (20 mL) for 1 h at 37 ˝C
and 150 rpm. At the end of the process, the solution was removed and SBA3 powders were washed
and dried following the same process used for SBA2 glass.
The structure of SBA3 and ion-exchanged SBA3 (named from now on SBA3-Cu0.01 and
SBA3-Cu0.05) was investigated by means of XRD (X’Pert Philips diffractometer) using the Bragg
Brentano camera geometry and the Cu-Ka incident radiation; the obtained patterns were analysed
with X’Pert High Score software and the PCPDF data bank. SEM-EDS analyses were performed to
estimate the morphology and the composition, in particular the effective Cu introduction, of the three
glasses. The composition of the glasses and the oxidation state of Cu were also investigated by means
of X-ray photoelectron spectroscopy (XPS—PHI 5000 VERSA PROBE, PHYSICAL ELECTRONICS).
Survey analyses were carried out to verify the glasses’ compositions, and high resolution spectra of C
and Cu were performed to individuate the oxidation state of copper.
The in vitro bioactivity of SBA3, SBA3-Cu0.01, and SBA3-Cu0.05 was evaluated by immersing
100 mg of glass powders in 100 mL of simulated body fluid (SBF-Kokubo [42]), maintained at 37 ˝C
and 150 rpm for 1, 3, 7, 14, 21, and 28 days (two samples for each time period). The pH of the solutions
was monitored every 2–3 days, and at the end of each incubation time the SBF solution was removed,
samples gently washed with bi-distilled water and acetone, filtered using disk filter paper, and dried at
37 ˝C overnight. Subsequently, samples were analysed by means of XRD and Field Emission Scanning
Electron Microscopy (FESEM, ZEISS, Jena, Germany) equipped with EDS to evaluate the precipitation
of hydroxyapatite (HAp) and the eventual influence of Cu in the bioactivity process.
The antibacterial effect of Cu-doped glasses was investigated by means of the inhibition halo test
previously described for SBA2 glass by using Cu-doped glass pellets, a standard S. aureus strain, and
respecting the NCCLS normative [39].
3. Results and Discussion
3.1. SBA2 Characterization
Figure 1 shows the morphological, compositional, and structural characterization of SBA2
powders. As can be observed (Figure 1a), the powders’ size is <20 µm and they have an irregular
shape due to the milling process. EDS analysis (Figure 1b) confirmed the presence of all elements
characteristics of the glass, except for boron—due to its low atomic weight, it was not detected by
the instrument. The Cr peak is due to the metallization process necessary for SEM observation.
Structural analysis (Figure 1c) evidenced an amorphous halo at about 2θ = 25˝–35˝ and a lack of any
discrete diffraction peaks, confirming the completely amorphous nature of the starting glass.
SBA2 powders were then subjected to the ion-exchange process in different copper salt solutions.
The pH of the solutions varied in different ranges, depending on the salt used and the concentration;
after 1 h of contact with glass powders, the pH of the solutions increased due to the exchange between
Na+ and Ca2+ ions from the glass and H+ ions from the solution (which is concurrent with the exchange
with Cu2+), reaching higher values. In the case of copper nitrate solutions, the pH of the solution
before the ion-exchange process varied between 3.9 and 4.7, and after the process the pH stabilized
between 4.6 and 6.2. Regarding copper chloride solutions, the starting pH varied between 3.8 and 4.8,
and after the process it reached values between 4.3 and 7.8. In the case of copper acetate solutions, the
pH of the solution before the ion-exchange process varied between 5.5 and 5.7, and after the process
the pH stabilized between 5.8 and 9.3. Finally, the pH of copper sulphate solutions changed between
4.3 and 5, and after the process reached values between 5.9 and 9.3, inclusive.
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The pH of the solution can have an impact on the dissolution of the glass; nevertheless, it was
reported that a strong increase of alkali dissolution was observed for bioactive glass with low silica
content below pH 3 [43]—the pH of the used solution does not reach this value. Moreover, the
ion-exchange process lasts only 1 h, whereas significant dissolution of bioactive glass with similar
composition was observed by L. Björkvik et al. only after 7 or 14 days of treatment at pH near 2.
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Figure 1. (a) Morphological; (b) compositional; and (c) structural analyses of SBA2 bioactive
glass powders.
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The structural characterization of ion-exchanged SBA2 glasses is reported in Figure 2.
The ion-exchange in copper(II) nitrate 0.1 M and 0.05 M solutions caused the precipitation of a
crystalline phase (Cu4(NO3)2(OH)6); on the contrary, the ion-exchange in a 0.01 M solution did not
cause any additional phase precipitation, as confirmed by the XRD spectra, which revealed only the
amorphous halo (Figure 2a). The same behaviour was observed for SBA2 powders ion-exchanged in
copper(II) chloride solution: the formation of a Cu2Cl(OH)3 phase was observed after the ion-exchange
in 0.1 M and 0.05 M solutions (Figure 2b), while any presence of crystallization peaks was estimated
for SBA2 powders ion-exchanged in copper(II) acetate (Figure 2c) and sulphate solutions (both 0.05 M
and 0.01 M) (Figure 2d).
 
Cu4(NO3)2(OH)6
a
Copper(II) nitrate 0.01M
Copper(II) nitrate 0.05M
Copper(II) nitrate 0.1M
c
Copper(II) acetate 0.01M
Copper(II) acetate 0.05M
d
Copper(II) acetate 0.01M
Copper(II) acetate 0.05M
Cu2Cl(OH)3
b
Copper(II) chloride 0.01M
Copper(II) chloride 0.05M
Copper(II) chloride 0.1M
Figure 2. XRD analyses of SBA2 glass ion exchanged in (a) copper(II) nitrate; (b) copper(II) chloride;
(c) copper(II) acetate; and (d) copper(II) sulphate solutions.
Figure 3 shows the results obtained from compositional analyses (EDS). As it can be observed, for
all glasses, Cu replaced both sodium and calcium, since a decrease of both elements was observed in
all glasses with respect to the estimated amount for SBA2 glass. The at % reduction of Na and Ca is a
function of the ion-exchange conditions: the ion-exchange in more concentrated solutions leads to a
greater decrease in the amount of these elements and, as a consequence, a higher amount of Cu was
incorporated in the glass.
However, as observed in XRD analysis, for some ion-exchange conditions, a precipitation of
Cu-containing crystalline phase occurred; then, in these cases, the amount of detected Cu includes
both the Cu of the crystalline phase and that incorporated in the amorphous glass network. Table 2
displays the amount of Cu estimated by EDS analyses and the presence of Cu-containing crystalline
phases individuated by XRD analysis for all exchanged glasses.
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Figure 3. Energy Dispersion Spectrometry (EDS) analyses of SBA2 powders before ion-exchange
after in (a) copper(II) nitrate (SBA2-Cu N); (b) copper(II) chloride (SBA2-Cu Cl); (c) copper(II) acetate
(SBA2-Cu A); and (d) copper(II) sulphate solutions (SBA2-Cu S).
Table 2. Summary of Cu amount and presence of a crystalline phase detected by EDS and XRD
analyses, respectively, for all ion-exchanged glasses.
Copper Solutions at % Cu Crystalline Phase
Copper(II) nitrate 0.1 M 9.2 ˘ 0.3 Yes
Copper(II) nitrate 0.05 M 4.5 ˘ 0.2 Yes
Copper(II) nitrate 0.01 M 3.7 ˘ 0.3 No
Copper(II) chloride 0.1 M 26.5 ˘ 0.6 Yes
Copper(II) chloride 0.05 M 9.9 ˘ 0.5 Yes
Copper(II) chloride 0.01 M 3.3 ˘ 0.5 No
Copper(II) acetate 0.05 M 7.4 ˘ 0.2 No
Copper(II) acetate 0.01 M 3.6 ˘ 0.5 No
Copper(II) sulphate 0.05 M 6.9 ˘ 0.1 No
Copper(II) sulphate 0.01 M 2.9 ˘ 0.1 No
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Since it was possible to introduce a higher amount of Cu in the glass by using copper(II) acetate as
precursor, avoiding at the same time the precipitation of crystalline phases, glass powders exchanged
in copper(II) acetate solutions were analysed by SEM-EDS. The morphological-compositional analysis
(Figure 4) showed the presence of some Cu-containing crystals (evidenced with red circles in Figure 4)
on SBA2 ion-exchanged in a copper(II) acetate 0.05 M solution, even if the presence of any additional
crystalline phase was not detected by XRD analysis.
 
20 m
C
C
O
Cu
Na
Si
P Ca
Cu
Cr
Figure 4. Morphological and compositional analyses of SBA2 ion exchanged in copper(II) acetate
0.05 M solution. Red circles evidenced a Cu-containing crystalline phase.
For this reason, the antibacterial test was performed on SBA2 powders ion-exchanged in copper(II)
acetate 0.01 M solution; the obtained result is reported in Figure 5. As can be observed, the glass pellets
were not able to create an inhibition halo towards S. aureus strain. The blue halo around the sample
(Figure 5b,c) is due to Cu diffusion in the agar, but it is not an inhibition zone since bacterial colonies
are visible inside the “blue area”. However, it seems that no bacteria proliferate under the sample
(Figure 5c), revealing the ability of this material to affect bacterial adhesion.
 

a b c
5 mm 5 mm 5 mm
Figure 5. Inhibition halo of SBA2 glass ion exchanged in copper(II) acetate 0.01 M solution. (a) time
zero; (b) front of the plate after 24 h of incubation; and (c) back of the plate after 24 h of incubation.
3.2. SBA3 Characterization
On the basis of results obtained for SBA2 glass, SBA3 powders were subjected to ion-exchange
process in an aqueous solution of copper(II) acetate 0.01 M and 0.05 M. Figure 6 shows the
structural analyses of SBA3 before and after ion exchange processes. As can be noticed, SBA3 and
SBA3-Cu0.01 are completely amorphous, while the SBA3-Cu0.05 spectrum shows a small peak at about
2 theta = 29.5˝, which is ascribable to CaCO3; the formation of this phase could be occurring during
the ion-exchange process.
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Figure 6. XRD analyses of SBA3 (a) before ion exchange; and after ion exchange in copper(II) acetate
solution (b) 0.01 M and (c) 0.05 M.
Morphological characterization (Figure 7) evidenced an altered surface morphology (i.e., a rougher
surface) for ion-exchanged glasses in comparison to the pristine one, in particular for SBA3-Cu0.05.
Compositional analyses confirmed the starting chemical composition of the SBA3 glass and the
presence of Cu peaks in both SBA3-Cu0.01 and SBA3-Cu0.05 spectra. The amount of introduced
Cu was 4.2 at % for SBA3-Cu0.01 and 14.2 at % for SBA3-Cu0.05; regarding SBA3-Cu0.01, the Cu
ion-exchange occurred with sodium, while the ion exchange in a more concentrated solution (0.05 M)
also led to an exchange with calcium (Table 3). The Cr peak visible in the EDS spectra is due to the
metallization process necessary for SEM observation.
Table 4 and Figure 8 show the results of XPS measurements. The XPS quantitative analyses
(Table 3) differ with respect to EDS analyses since EDS has a larger interaction volume then XPS
(microns vs. nanometers); however, as evidenced with EDS measurements, the atomic percentage of
Cu increased by increasing the concentration of ion-exchange solution; contemporaneously, sodium
and calcium contents decreased. Al, B, and P were not detected.
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Figure 7. SEM-EDS analyses of (a) SBA3; (b) SBA3-Cu0.01; and (c) SBA3-Cu0.05.
Table 3. EDS analysis: atomic percentages of SBA3, SBA3-Cu0.01, and SBA3-Cu0.05.
EDS SBA3 SBA3-Cu0.01 SBA3-Cu0.05
Elements at % at % at %
Na 32.1 27.7 22.7
Al 1.6 1.1 2
Si 38.9 39.5 37.9
P 0.6 0.7 0.7
Ca 26.9 26.9 22.5
Cu 0 4.2 14.1
 
Figure 8. XPS detailed analyses of Cu 2p region of SBA3-Cu0.01 and SBA3-Cu0.05.
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In order to estimate the oxidation state of introduced Cu, a detailed analysis of the Cu (Cu 2p)
region was performed. The XPS spectra show the peaks of Cu 2p3/2 and Cu 2p1/2 characteristic of
Cu element; Cu(II) can be distinguished from Cu(I) and Cu0 since Cu(II) shows shake-up satellite
features at about 943–941 eV and 961 eV [44]. These satellite peaks are well visible in SBA3-Cu0.01 and
SBA3-Cu0.05 spectra, so the glass surface was enriched with Cu(II) ions.
Table 4. Atomic percentages of elements obtained from XPS analyses of SBA3, SBA3-Cu0.01
and SBA3-Cu0.05.
XPS-Elements SBA3 SBA3-Cu0.01 SBA3-Cu0.05
Na 56.9 38.2 29.4
Si 25.8 43.3 46.6
Ca 17.3 11.6 7.0
Cu 0.00 6.9 17.0
SBA3, SBA3-Cu0.01 and SBA3-Cu0.05 were subjected to in vitro bioactivity test to estimate the
ability of SBA3 to induce the precipitation of hydroxyapatite and to verify the possible influence of Cu
introduction and ion-exchange process on bioactivity. Figure 9 shows the XRD analyses performed on
all three glasses before and after immersion in SBF solution up to 28 days. With regards to SBA3, after
1 day of SBF immersion, a broad halo between 20˝ and 25˝ ascribable to silica gel formation can be
noticed. After 3 days of soaking, two peaks at 2 theta = 25.879˝ and 32.054˝ appeared; these peaks were
attributed to hydroxyapatite (HAp) (ref. pattern 00-001-1008). The introduction of Cu did not influence
the bioactivity mechanism: after 1 day of soaking in SBF, the characteristic halo of silica gel was also
noticed in SBA3-Cu0.01 and SBA3-Cu0.05 spectra, together with a peak at about 2 theta = 29.452˝
ascribable to CaCO3 (ref. pattern 01-0830578). Calcite is a precursor of HAp and its precipitation has
also been observed by other authors [45]. HAp precipitation was also clearly observed for Cu-doped
glass after 3 days of immersion.
Calcite
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Figure 9. XRD spectra of SBA3 (a); SBA3-Cu0.01 (b); and SBA3-Cu0.05 (c) before and after immersion
in simulated body fluid (SBF) for 1, 3, 7, 14, 21, and 28 days. HAp: Hydroxyapatite.
The results of FESEM-EDS analyses after in vitro bioactivity test are reported in Figure 10.
The figure shows the sample morphology of SBA3, SBA3-Cu0.01, and SBA3-Cu0.05 after 21
(Figure 10a–c) and 28 (Figure 10g–i) days of immersion in SBF solution, and the compositional analysis
(Figure 10d–f) of SBA3, SBA3-Cu0.01, and SBA3-Cu0.05 after 21 days of SBF treatment. All glasses
showed a surface morphology clearly different with respect to the powders before SBF treatment, since
they were covered by nanometric crystals rich in Ca and P. Micrographs after 21 and 28 days evidenced
the presence of crystals grown on the glass powders; the local EDS analysis after 21 days of immersion
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shows very intense peaks of Ca and P. EDS analyses after 28 days were not reported since they are
very similar to those after 21 days.
 
fed
a b c
2 m 2 m 2 m
2 m 2 m 2 m
g h i
Figure 10. FESEM and EDS analysis of (a,d) SBA3; (b,e) SBA3-Cu0.01; and (c,f) SBA3-Cu0.05 after
21 days of immersion in SBF solution, and FESEM micrographs of (g) SBA3; (h) SBA3-Cu0.01; and
(i) SBA3-Cu0.05 after 28 days of SBF treatment.
Then, the performed analyses indicated that the Cu introduced by ion-exchange process does not
alter the bioactivity of pristine glass (SBA3), contrary towhat has been observed by other authors [26,30]
for Cu-doped glasses using sol-gel process or melt and quenching technique. In fact, Srivastava et al.
reported that the bioactivity of melt-derived 45S5 glass doped with more than 1 wt % of CuO decreases,
since Cu enhances the chemical durability of silicate glasses [30]. The same result was observed by
Bejarano et al. for Cu-doped sol-gel glasses [26]—the presence of Cu in the glass decreased the ability to
form surface crystalline apatite, since the incorporation of Cu generated a lower amount of Ca released
and a competition between Cu2+ and Ca2+ ions in solution for the precipitation of phosphate species,
which explains the lower bioactivity of the Cu-doped glasses. In the present work, Cu was introduced
in very low amounts and confined in the outer surface layers. For these reasons, it is unlikely that
its presence could strongly and negatively affect the release of the ions involved in the bioactivity
mechanism from the doped glass (sodium and calcium in this case), as already observed by authors
in a glass ion-exchanged with silver [46,47]. Moreover, as reported in Figure 7, the ion-exchange
process caused an alteration of the surface morphology, with increasing roughness. As a consequence
of this alteration, aside from the decrease of sodium and calcium ions (partially substituted by Cu),
which should slow the bioactivity kinetics, a faster dissolution rate can be hypothesized [48] which,
in turn, can positively affect the glass bioactivity, with a compensative effect toward sodium and
calcium depletion.
Antibacterial testing towards a strain of S. aureus is reported in Figure 11. As can be observed, Cu
diffused from both samples in the agar plate (evidenced with red dotted line in Figure 11); SBA3-Cu0.01
was not able to produce an inhibition zone, while SBA3-Cu0.05 created a significant inhibition halo
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of about 1 mm. In addition, in this case, no bacteria proliferated under SBA3-Cu0.01 (Figure 11c),
revealing the ability of this sample to avoid bacterial adhesion.
 
b
Inhibition halo
Cu diffusionCu diffusion
a
5 mm 5 mm
Inhibition halo
Cu diffusion
5 mm 5 mm
Cu diffusion
dc
Figure 11. Inhibition halo test of (a,c) SBA3-Cu0.01; and (b,d) SBA3-Cu0.05; towards S. aureus strain,
(a,b) front; and (c,d) back of the plate.
4. Conclusions
In this work, two bioactive glasses in the system SiO2, Na2O, CaO, P2O5, B2O3, Al2O3 (SBA2
and SBA3) have been synthesized by melt and quenching route and doped with Cu by ion-exchange
in aqueous solutions. The effect of doping has been evaluated by morphological, compositional,
and structural viewpoints, as well as in terms of bioactivity (HAp growth by soaking in SBF) and
antibacterial properties (inhibition halo test).
Depending on both the glass composition and the ion-exchange conditions, Cu was introduced
in the amorphous network as ionic species and as copper salts precipitates. By tailoring the glass
reactivity (connected with the amount of monovalent modifying ions and the glass network degree of
opening) and by proper selection of the exchange solution (in terms of typology of the copper salt and
concentration), the process was optimized in order to enrich the glass surface with Cu(II) ions.
The ion-exchange process determined a modification of the morphology of the glass surface,
inducing a higher roughness. The bioactivity of the glass, in terms of HAp growth by soaking in SBF,
was not affected by the presence of Cu on the surface, contrary to what has been observed in literature
for bioactive glasses dopedwith Cu in thewhole bulk, where a competition between Ca2+ and Cu2+ ions
has been observed in the first stages of the bioactivity mechanism. This difference from the literature
can be explained by the relatively low amount of copper ions introduced by ion-exchange and their
presence only in a very thin surface layer. This, in synergy with the increased surface roughness, which
partially compensates for the eventual lower ion release from the glass, led to an unaltered ability of
the glass to release ions involved in the bioactivity mechanism. Antibacterial testing on the optimized
Cu-doped bioactive glasses revealed their ability to limit bacterial adhesion and proliferation.
Materials 2016, 9, 405 14 of 16
Further investigations could be addressed to assess the biocompatibility of the glass modified with
this new approach, as well as its ability to stimulate angiogenesis on human endothelial cell cultures.
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